vs
Side-by-side financial comparison of Claros Mortgage Trust, Inc. (CMTG) and PCB BANCORP (PCB). Click either name above to swap in a different company.
Claros Mortgage Trust, Inc. is the larger business by last-quarter revenue ($46.7M vs $29.2M, roughly 1.6× PCB BANCORP). On growth, PCB BANCORP posted the faster year-over-year revenue change (11.3% vs -22.4%). Over the past eight quarters, PCB BANCORP's revenue compounded faster (10.4% CAGR vs -10.9%).
Claros Mortgage Trust, Inc. is a U.S.-based real estate investment trust that invests in diversified mortgage-related assets, including residential and commercial mortgage loans and mortgage-backed securities. It pursues stable, risk-adjusted long-term returns for shareholders via rigorous asset evaluation and active portfolio management.
PCB Bank is an American community bank that focuses on the Korean-American community based in California and offers commercial banking services. It has branches in 8 states and is the third largest Korean American Bank after Bank of Hope and Hanmi Bank.
CMTG vs PCB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $46.7M | $29.2M |
| Net Profit | $-219.2M | — |
| Gross Margin | — | — |
| Operating Margin | — | 45.0% |
| Net Margin | -468.9% | — |
| Revenue YoY | -22.4% | 11.3% |
| Net Profit YoY | -117.7% | — |
| EPS (diluted) | $-1.56 | $0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $46.7M | $29.2M | ||
| Q3 25 | $46.1M | $30.4M | ||
| Q2 25 | $51.6M | $29.3M | ||
| Q1 25 | $43.4M | $26.9M | ||
| Q4 24 | $60.2M | $26.2M | ||
| Q3 24 | $64.9M | $25.3M | ||
| Q2 24 | $64.5M | $24.2M | ||
| Q1 24 | $58.8M | $23.9M |
| Q4 25 | $-219.2M | — | ||
| Q3 25 | $-9.5M | $11.4M | ||
| Q2 25 | $-181.7M | $9.1M | ||
| Q1 25 | $-78.6M | $7.7M | ||
| Q4 24 | $-100.7M | — | ||
| Q3 24 | $-56.2M | $7.8M | ||
| Q2 24 | $-11.6M | $6.3M | ||
| Q1 24 | $-52.8M | $4.7M |
| Q4 25 | — | 45.0% | ||
| Q3 25 | — | 52.3% | ||
| Q2 25 | — | 43.3% | ||
| Q1 25 | — | 40.2% | ||
| Q4 24 | — | 39.3% | ||
| Q3 24 | — | 42.2% | ||
| Q2 24 | — | 36.3% | ||
| Q1 24 | — | 27.2% |
| Q4 25 | -468.9% | — | ||
| Q3 25 | -20.7% | 37.5% | ||
| Q2 25 | -351.9% | 31.0% | ||
| Q1 25 | -181.3% | 28.8% | ||
| Q4 24 | -167.2% | — | ||
| Q3 24 | -86.7% | 30.8% | ||
| Q2 24 | -17.9% | 25.9% | ||
| Q1 24 | -89.7% | 19.6% |
| Q4 25 | $-1.56 | $0.65 | ||
| Q3 25 | $-0.07 | $0.78 | ||
| Q2 25 | $-1.30 | $0.62 | ||
| Q1 25 | $-0.56 | $0.53 | ||
| Q4 24 | $-0.72 | $0.46 | ||
| Q3 24 | $-0.40 | $0.52 | ||
| Q2 24 | $-0.09 | $0.43 | ||
| Q1 24 | $-0.39 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $173.2M | $207.1M |
| Total DebtLower is stronger | $3.2B | — |
| Stockholders' EquityBook value | $1.5B | $390.0M |
| Total Assets | $4.7B | $3.3B |
| Debt / EquityLower = less leverage | 2.06× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $173.2M | $207.1M | ||
| Q3 25 | $339.5M | $369.5M | ||
| Q2 25 | $209.2M | $263.6M | ||
| Q1 25 | $127.8M | $214.3M | ||
| Q4 24 | $99.1M | $198.8M | ||
| Q3 24 | $113.9M | $193.1M | ||
| Q2 24 | $148.2M | $177.6M | ||
| Q1 24 | $232.5M | $239.8M |
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.7B | — | ||
| Q2 25 | $4.0B | — | ||
| Q1 25 | $4.7B | — | ||
| Q4 24 | $4.9B | — | ||
| Q3 24 | $5.1B | — | ||
| Q2 24 | $5.3B | — | ||
| Q1 24 | $5.5B | — |
| Q4 25 | $1.5B | $390.0M | ||
| Q3 25 | $1.7B | $384.5M | ||
| Q2 25 | $1.8B | $376.5M | ||
| Q1 25 | $1.9B | $370.9M | ||
| Q4 24 | $2.0B | $363.8M | ||
| Q3 24 | $2.1B | $362.3M | ||
| Q2 24 | $2.2B | $353.5M | ||
| Q1 24 | $2.2B | $350.0M |
| Q4 25 | $4.7B | $3.3B | ||
| Q3 25 | $5.4B | $3.4B | ||
| Q2 25 | $5.8B | $3.3B | ||
| Q1 25 | $6.7B | $3.2B | ||
| Q4 24 | $7.0B | $3.1B | ||
| Q3 24 | $7.3B | $2.9B | ||
| Q2 24 | $7.6B | $2.9B | ||
| Q1 24 | $7.8B | $2.9B |
| Q4 25 | 2.06× | — | ||
| Q3 25 | 2.09× | — | ||
| Q2 25 | 2.29× | — | ||
| Q1 25 | 2.42× | — | ||
| Q4 24 | 2.44× | — | ||
| Q3 24 | 2.44× | — | ||
| Q2 24 | 2.46× | — | ||
| Q1 24 | 2.47× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-30.5M | $26.6M |
| Free Cash FlowOCF − Capex | — | $24.4M |
| FCF MarginFCF / Revenue | — | 83.6% |
| Capex IntensityCapex / Revenue | — | 7.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $46.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-30.5M | $26.6M | ||
| Q3 25 | $8.8M | $16.4M | ||
| Q2 25 | $-5.8M | $4.9M | ||
| Q1 25 | $-35.8M | $2.3M | ||
| Q4 24 | $84.5M | $39.0M | ||
| Q3 24 | $39.2M | $11.9M | ||
| Q2 24 | $5.5M | $14.6M | ||
| Q1 24 | $21.5M | $8.2M |
| Q4 25 | — | $24.4M | ||
| Q3 25 | — | $16.2M | ||
| Q2 25 | — | $3.8M | ||
| Q1 25 | — | $1.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | — | $11.9M | ||
| Q2 24 | — | $12.8M | ||
| Q1 24 | — | $6.0M |
| Q4 25 | — | 83.6% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 13.1% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | 133.2% | ||
| Q3 24 | — | 46.8% | ||
| Q2 24 | — | 53.1% | ||
| Q1 24 | — | 25.2% |
| Q4 25 | — | 7.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 2.8% | ||
| Q4 24 | — | 15.5% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 7.3% | ||
| Q1 24 | — | 9.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | 2.33× | ||
| Q1 24 | — | 1.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMTG
| Real Estate Owned Portfolio | $34.2M | 73% |
| Other | $11.1M | 24% |
| Mixed Use Property Fixed Rents | $1.4M | 3% |
PCB
Segment breakdown not available.